ABT-101(Alpha Beta Therapeutics)

N/A

Report date: 2024/07/08 16:44:43

Base Information

Drug NameABT-101(Alpha Beta Therapeutics)
Drug Alias NameABT-101ABT101
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionIntegrin alpha-V/beta-3 antagonists
TargetsIntegrin alpha-V/beta-3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlpha Beta Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesAlpha Beta Therapeutics
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A